COMPREHENSIVE RISK ASSESSMENT OF THROMBOCYTOPENIA IN ONCOLOGY PATIENTS: FROM PREDICTORS TO PERSONALIZED THERAPY

RAXIMOV Nodir Maxammatkulovich, SHAXANOVA Shaxnoza Shavkatovna, ASSATULAEV Akmal Farxadovich, KHAKIMOV Alisher Abduraxmonovich

Journal of Biomedicine and Practice – Biomeditsina va amaliyot jurnali · 2025-yil

Annotatsiya

The presented study focuses on a multi-parametric risk assessment of thrombocytopenia in an oncology cohort using modern diagnostic methodologies. A comprehensive prediction algorithm has been developed, integrating clinical, laboratory, and molecular genetic predictors. The article aims to systematize diagnostic approaches to assessing thrombocytopenia risk from a multifactorial analysis perspective in palliative oncology. The paper presents a conceptual approach that includes quantitative assessment of baseline platelet reserve, analysis of genetic predisposition, evaluation of platelet functional potential, and molecular genetic risk stratification.

Maqola ma’lumotlari
MualliflarRAXIMOV Nodir Maxammatkulovich, SHAXANOVA Shaxnoza Shavkatovna, ASSATULAEV Akmal Farxadovich, KHAKIMOV Alisher Abduraxmonovich
JurnalJournal of Biomedicine and Practice – Biomeditsina va amaliyot jurnali
Nashr sanasi2025-11-21
Jild10
Son5
TilRus

Kalit so‘zlar

тромбоцитопения, онкология, незрелая фракция тромбоцитов, тромбопоэтин, молекулярно-генетические маркер, thrombocytopenia, oncology, immature platelet fraction, thrombopoietin, molecular genetic markers, тромбоцитопения, онкология, тромбоцитларнинг етилмаган фракцияси, тромбопоэтин, молекуляр-генетик маркерлар

Ilmiy soha

Journal of Biomedicine and Practice – Biomeditsina va amaliyot jurnali jurnalidan boshqa maqolalar

Journal of Biomedicine and Practice – Biomeditsina va amaliyot jurnali — barcha maqolalar